Growth Metrics

Vertex Pharmaceuticals (VRTX) EBT Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.59%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -313.33%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 71.54%
7 Evaxion A 62.56 Bn 62.54 Bn - -79.57%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 9,460.35%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 71.54%
Dec 31, 2025 17.11%
Sep 30, 2025 6.10%
Jun 30, 2025 137.83%
Mar 31, 2025 -42.90%
Dec 31, 2024 -0.97%
Sep 30, 2024 3.81%
Jun 30, 2024 -391.97%
Mar 31, 2024 43.48%
Dec 31, 2023 6.58%
Sep 30, 2023 0.24%
Jun 30, 2023 13.38%
Mar 31, 2023 -6.63%
Dec 31, 2022 23.64%
Sep 30, 2022 8.64%
Jun 30, 2022 2,417.65%
Mar 31, 2022 16.31%
Dec 31, 2021 -1.99%
Sep 30, 2021 45.17%
Jun 30, 2021 -105.36%
Mar 31, 2021 24.85%
Dec 31, 2020 31.27%
Sep 30, 2020 955.49%
Jun 30, 2020 152.12%
Mar 31, 2020 105.37%
Dec 31, 2019 1,983.12%
Sep 30, 2019 -48.23%
Jun 30, 2019 51.04%
Mar 31, 2019 49.16%
Dec 31, 2018 -71.10%
Sep 30, 2018 132.72%
Jun 30, 2018 510.01%
Mar 31, 2018 -15.34%
Dec 31, 2017 453.74%
Sep 30, 2017 -968.73%
Jun 30, 2017 297.03%
Mar 31, 2017 928.08%
Dec 31, 2016 126.70%
Sep 30, 2016 57.79%
Jun 30, 2016 90.56%
Mar 31, 2016 84.57%
Dec 31, 2015 57.42%
Sep 30, 2015 44.48%
Jun 30, 2015 -20.50%
Mar 31, 2015 14.22%
Dec 31, 2014 -812.68%
Sep 30, 2014 -40.10%
Jun 30, 2014 -194.45%
Mar 31, 2014 46.68%
Dec 31, 2013 75.77%
Sep 30, 2013 -2,225.90%
Jun 30, 2013 -273.43%
Mar 31, 2013 -593.45%
Dec 31, 2012 -138.32%
Sep 30, 2012 -102.55%
Mar 31, 2012 149.92%
Dec 31, 2011 216.86%
Sep 30, 2011 196.01%
Mar 31, 2011 -7.52%
Dec 31, 2010 -19.50%
Sep 30, 2010 -39.71%
Jun 30, 2010 -25.79%
Mar 31, 2010 -0.68%